doi:10.1016/j.iac.2018.04.003 Sperr WR, Jordan JH, Fiegl M, et al
Digestive discomfort, whether constipation or diarrhea, can disrupt your everyday life, while chronic digestive problems can have an even bigger impact on your long-term quality of life, from pain and embarrassment to missed time with loved ones and increased cancer risk
A phase III trial (NCT01909453) compares the effectiveness and safety of LGX818 with MEK162 to vemurafenib and LGX818 monotherapy in patients with locally progressed, unresectable, or metastatic melanoma with the BRAF V600 mutation in two parts
View Study [3]"Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity" Garvey WT et al., 2025 Finding: The REDEFINE 1 Phase 3 trial showed CagriSema achieved 20.4% weight loss versus 3% with placebo over 68 weeks in 3,417 participants